R&D News | pharmaphorum

News

Otsuka has high hopes for its 'drug creation engine' acquisi...

Otsuka is paying $430 million for a US clinical-stage biotech company it hopes will act as a ‘drug creation engine’ to accelerate its research into kidney diseases.

AstraZeneca

AZ forges surprise R&D deal with virus gene therapy biotech

MedImmune, the R&D arm of AstraZeneca has teamed up with California based 4DMT, a next-generation virus-based gene therapy research house developing a treatment for chronic lung disease

News

Fotivda approved in Scotland for kidney cancer

The Scottish Medicines Consortium (SMC) has recommended regular NHS funding for EUSA Pharma's kidney cancer drug Fotivda, enabling around 165 patients a year to access the treatment.

News

Hope for Alzheimer’s treatment after promising study results

Biogen and Eisai said their latest clinical study confirmed the amyloid hypothesis and might lead to the first drug successfully treating Alzheimer’s disease, instantly bumping their share

News

Study indicates potential breakthrough HIV drug

French biotech Abivax might be on the verge of HIV cure and prevention discovery, after achieving a significant reduction of viral load patients during the first 28 days of treatment.

News

Review finds medical benefits of cannabis-based drugs

The use of medical cannabis in the UK has moved a step closer, after the home secretary asked for advice following a review that concluded that there is evidence of therapeutic benefit.

Otsuka has high hopes for its 'drug creation engine' acquisi...

AZ forges surprise R&D deal with virus gene therapy biotech

Fotivda approved in Scotland for kidney cancer

Hope for Alzheimer’s treatment after promising study results

Study indicates potential breakthrough HIV drug

Review finds medical benefits of cannabis-based drugs

Bavarian Nordic has found its new CEO

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks